Annual Shareholders Equity
$4.71 M
-$1.94 M-29.17%
December 31, 2024
Summary
- As of March 13, 2025, REVBW annual stockholders equity is $4.71 million, with the most recent change of -$1.94 million (-29.17%) on December 31, 2024.
- During the last 3 years, REVBW annual shareholders equity has risen by +$4.81 million (+4833.47%).
- REVBW annual shareholders equity is now -29.17% below its all-time high of $6.65 million, reached on December 31, 2023.
Performance
REVBW Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$4.71 M
+$2.03 M+76.11%
December 31, 2024
Summary
- As of March 13, 2025, REVBW quarterly stockholders equity is $4.71 million, with the most recent change of +$2.03 million (+76.11%) on December 31, 2024.
- Over the past year, REVBW quarterly shareholders equity has increased by +$2.03 million (+76.11%).
- REVBW quarterly shareholders equity is now -50.30% below its all-time high of $9.47 million, reached on March 31, 2024.
Performance
REVBW Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
REVBW Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.2% | +76.1% |
| 3 y3 years | +4833.5% | +76.1% |
| 5 y5 years | +38.0% | +76.1% |
REVBW Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.2% | +4833.5% | -50.3% | +355.5% |
| 5 y | 5-year | -29.2% | +4833.5% | -50.3% | +355.5% |
| alltime | all time | -29.2% | +4833.5% | -50.3% | +355.5% |
Revelation Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.71 M(-29.2%) | $4.71 M(+76.1%) |
| Sep 2024 | - | $2.67 M(+134.4%) |
| Jun 2024 | - | $1.14 M(-88.0%) |
| Mar 2024 | - | $9.47 M(+42.5%) |
| Dec 2023 | $6.65 M(+531.6%) | $6.65 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.05 M(-1158.1%) | - |
| Jun 2022 | - | -$1.84 M(+1770.9%) |
| Mar 2022 | - | -$98.51 K(-1.0%) |
| Dec 2021 | -$99.47 K(-102.9%) | -$99.47 K(-102.7%) |
| Sep 2021 | - | $3.66 M |
| Dec 2020 | $3.41 M | - |
FAQ
- What is Revelation Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Revelation Biosciences?
- What is Revelation Biosciences annual shareholders equity year-on-year change?
- What is Revelation Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Revelation Biosciences?
- What is Revelation Biosciences quarterly shareholders equity year-on-year change?
What is Revelation Biosciences annual stockholders equity?
The current annual shareholders equity of REVBW is $4.71 M
What is the all time high annual shareholders equity for Revelation Biosciences?
Revelation Biosciences all-time high annual stockholders equity is $6.65 M
What is Revelation Biosciences annual shareholders equity year-on-year change?
Over the past year, REVBW annual stockholders equity has changed by -$1.94 M (-29.17%)
What is Revelation Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of REVBW is $4.71 M
What is the all time high quarterly shareholders equity for Revelation Biosciences?
Revelation Biosciences all-time high quarterly stockholders equity is $9.47 M
What is Revelation Biosciences quarterly shareholders equity year-on-year change?
Over the past year, REVBW quarterly stockholders equity has changed by +$2.03 M (+76.11%)